Vaccine Therapy in Treating Patients With Metastatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines made from a peptide may make the body build an immune response and kill
tumor cells.
PURPOSE: Randomized phase I trial to study the effectiveness of vaccine therapy in treating
patients who have metastatic cancer that has not responded to previous therapy.